A study involving 121,492 adults aged 60 or older found that those using nitrogen-containing bisphosphonates (NBP), commonly prescribed for osteoporosis, had a 16% lower risk of developing Alzheimer’s disease and related dementias compared to non-users. Users also showed a 24% reduced risk when compared to people on other osteoporosis medications. The study, published in *Alzheimer's & Dementia*, suggests a potential link between bone health and brain health but does not prove causation; further clinical trials are needed to confirm these findings.
Written by the local model on 2026-09-17,
using this article's own text rather than the other coverage of the
same event (that is the story summary below).
Story summary
Ching-Lung Cheung, an associate professor at the Department of Pharmacology and Pharmacy within the Li Ka Shing Faculty of Medicine at the University of Hong Kong, led a study involving 121,492 adults aged 60 or older who had recently been diagnosed with osteoporosis or suffered serious fractures. The research found that those using nitrogen-containing bisphosphonates (NBP), such as alendronate and zoledronate, had a 16% lower risk of developing Alzheimer's disease compared to non-users. Additionally, NBPs showed a 24% reduced risk when compared to other osteoporosis medications. The study highlights the potential connection between bone health and brain function, suggesting that maintaining strong bones might also help in reducing the risk of dementia.
Written for “Bone Drugs Lower Alzheimer's Risk” on 2026-09-17,
grounded in this article and the 0 other(s) covering the same event.
Commonly used osteoporosis drugs were linked to a lower risk of Alzheimer’s disease and other types of dementia in a large study of older adults.
asserted
drugs → use → adults
Among a group of 121,492 adults age 60 or older, the use of nitrogen-containing bisphosphonates (NBP) was associated with a 16% lower risk of developing Alzheimer’s disease and related dementias compared to those who did not take osteoporosis medications.
asserted
who → contain → medications
The risk was 24% less compared to people taking other types of osteoporosis medications.
asserted
risk → compare → medications
A nitrogen-containing bisphosphonate is a type of medication used to slow bone loss and reduce fracture risk, mainly in people with osteoporosis.
asserted
bisphosphonate → contain → osteoporosis
Some common types include alendronate, ibandronate, risedronate and zoledronate.
asserted
types → include → alendronate
Osteoporosis occurs when the bones become weaker and more likely to break due to a loss of bone mass, according to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
uncertain
bones → occur → Diseases
All adults in the Hong Kong study had recently been diagnosed with osteoporosis or suffered a serious fracture in the spine, humerus, wrist or hip.
asserted
adults → diagnose → spine
None had previously taken medication for osteoporosis.
asserted
None → take → osteoporosis
"Emerging evidence points to a bone-brain axis, suggesting a close link between bone and brain health," study author Ching-Lung Cheung, associate professor in the Department of Pharmacology and Pharmacy at the University of Hong Kong’s Li Ka Shing Faculty of Medicine, told Fox News Digital.
asserted
Cheung → point → Digital
"Our previous studies and those of others have found that people with low bone mass or osteoporosis are more likely to develop dementia later in life.
asserted
people → find → life
This highlights the importance of maintaining good bone health, which may also help reduce the risk of dementia.
uncertain
which → highlight → dementia
"
The study, which was published in Alzheimer’s & Dementia, was observational in design.
asserted
which → publish → design
"Our findings therefore do not prove that bisphosphonate use reduces dementia risk; this needs confirmation in a clinical trial," Cheung said.
asserted
Cheung → prove → trial
"Generalizability is another consideration, as our study involved only a Chinese population, and it remains uncertain whether the findings apply to other populations.
asserted
findings → involve → populations
"
Another limitation is that baseline cognitive testing was unavailable, which means patients who already developed cognitive impairment may have been less likely to receive osteoporosis treatment.
uncertain
who → mean → treatment
The researchers also lacked information about the severity of participants’ osteoporosis and bone fractures, as well as their use of over-the-counter calcium and vitamin D.
Other external factors, such as education level, social isolation, air pollution and vision loss, could also have affected dementia risk, they acknowledged.
uncertain
they → lack → risk
Although the study findings suggest that older patients receiving NBPs for osteoporosis or fragility fractures had lower rates of Alzheimer’s and related dementias, they do not yet justify prescribing bisphosphonates specifically to prevent or treat the disease.
asserted
they → suggest → disease
The authors called for more research that will include wider populations, with a focus on whether gender may play a role in the reduced risk.
uncertain
gender → call → risk
"The next step is to confirm our observational findings in a clinical trial," Cheung said.
asserted
Cheung → confirm → trial
"If the benefit is demonstrated, it could have important implications for dementia management."
uncertain
it → demonstrate → management
"We hope these findings encourage patients and healthcare professionals to weigh the overall benefits and risks and use appropriate treatment when indicated."
asserted
findings → hope → treatment
The Aporia
